| |
CARD ID
 |
894 |
| Type of strain |
Transgenic. |
| Strain name |
C57BL/6-Tg(CAG-hG8(M))N673Glp |
| Internal Code |
hGal8 (M) |
| Submitter |
- - |
| Submitter affiliation or code |
- |
| Stock Type |
|
| Material Transfer Conditions |
It is necessary to consent to the submitter.
|
| Production method |
In-house breading.
|
Origin
(In-house) |
Organization |
Galpharma Co.Ltd. |
| Organization code |
Gal |
| Developer |
Mitsuomi Hirashima |
Origin
(From other organizations) |
Organization |
|
| Organization code |
|
| Developer |
|
| Year introduced |
|
Introduced
Generation |
|
| Remarks |
|
| |
Gene symbol
|
hG8(M) |
| Gene name |
human Galectin 8(M) |
| Allele symbol |
|
| Allele name |
|
| MGI |
|
| Chromosome |
Unknown |
| Gene classification |
Gene to express(transgenic) |
| Method |
MicroInjection |
| OMIM |
|
|
| |
PCR Primer |
h Gal-8.Forward
|
ggATCTgCAgAATggCAgCAgCAT
|
|
h Gal-8.Reverse
|
gTCTCCATTAATTTCCAgCgTgTC
|
|
| reference information 1 |
| |
Author
|
Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T. |
| Title |
Galectin-8 modulates neutrophil function via interaction with integrin alphaM. |
| Journal |
Glycobiology. |
| Volume |
11 |
| Page |
755-63 |
| Year |
2003 |
|
PMID
|
|
|
| reference information 2 |
| |
Author
|
Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, Shoji H, Nakamura T. |
| Title |
Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. |
| Journal |
FEBS Lett. |
| Volume |
10 |
| Page |
2058-64 |
| Year |
2005 |
|
PMID
|
|
|
|
Disease , Applicable field information
|
| |
Disease name,
Applicable field
|
cancer, Immunology, Development
|
|
|
